The proposal builds on innovative technologies patented and published by my group. The project has two specific objectives: 1) to deliver the new generation of intelligent biomedical devices that have the capacity to control infections, inflammation and foreign body response; and 2) to develop a novel, non-invasive and affordable point of care diagnostic technology for early detection of chronic kidney diseases, and kidney and bladder cancers that is much needed in this space of healthcare.
My research objectives centre on new technology development for improving diagnostics and therapeutics applied to skin. I have developed and patented novel devices for minimally invasive topical drug delivery and skin sampling. My leadership and tangible research outcomes are now enabling previously impossible skin research to be done and now are also impacting the commercial sector in addition to creating new knowledge in the field.